Michele Korfin
Directeur/Bestuurslid bij ORGANOGENESIS HOLDINGS INC.
Vermogen: 399 557 $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Michele Korfin
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
110
| Subsidiary | Biotechnology | 110 |
| Subsidiary | Biotechnology | 37 | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart.
25
| Private Company | Miscellaneous Commercial Services | 25 |
| Public Company | Pharmaceuticals: Major | 21 | |
| Public Company | Medical Specialties | 21 | |
| Subsidiary | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Michele Korfin via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Sales & Marketing Corporate Officer/Principal Director/Board Member Chief Tech/Sci/R&D Officer | |
| ALLOGENE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Founder Founder Founder General Counsel Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member | |
| UROGEN PHARMA LTD. | Biotechnology | Chairman Director/Board Member Consultant / Advisor Director/Board Member Director/Board Member | |
| JUNO THERAPEUTICS INC | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Treasurer | |
| ARNO THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Founder Chairman Director/Board Member | |
| KRONOS BIO, INC. | Pharmaceuticals: Major | Founder Founder Founder Consultant / Advisor | |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor Founder Founder Consultant / Advisor | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director of Finance/CFO | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Director of Finance/CFO | |
| University of Michigan | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
Two River Group Holdings LLC
 Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | Investment Managers | Founder Founder Chairman | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
| Princeton University | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
76bio, Inc.
 76bio, Inc. Pharmaceuticals: MajorHealth Technology 76Bio, Inc. is a private company that aims to develop transformational therapies for patients with life-threatening diseases. The company is based in New York, NY. The company focuses on pioneering the next generation of degradation by design. 76Bio was founded by Joshua A. Kazam, David M. Tanen, Marius Pop, Christopher Wilfong, Ben Stone, Angela Koehler, Arie S. Belldegrun, and K. Dane Wittrup. Christopher Wilfong has been the CEO since incorporation. | Pharmaceuticals: Major | Founder Founder Founder | |
| CAPRICOR THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Secretary Director/Board Member Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Sales & Marketing | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director of Finance/CFO | |
| CARDINAL HEALTH, INC. | Medical Distributors | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| Gladstone Foundation (CA) | Director/Board Member Director/Board Member Director/Board Member | ||
| University of Medicine & Dentistry of New Jersey | College/University | Chairman Corporate Officer/Principal Corporate Officer/Principal | |
| AUTOLUS THERAPEUTICS PLC | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| The Hebrew University of Jerusalem | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| Robert B. Willumstad School of Business | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Danube Pharmaceuticals, Inc.
 Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
| University of Oxford | College/University | Undergraduate Degree Doctorate Degree | |
| TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Bunge Ltd.
 Bunge Ltd. Agricultural Commodities/MillingProcess Industries Bunge Global SA operates as a holding company. engages in the supply and transportation of agricultural commodities. It operates through the following segments: Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy. The Agribusiness segment is involved in the purchase, storage, transportation, processing, and sale of agricultural commodities and commodity products. The Refined and Specialty Oils segment engages in the processing, production, and marketing of products derived from vegetable oils. The Milling segment consists of the processing, production, and marketing of products derived primarily from wheat and corn. The Sugar and Bioenergy segment includes the manufacture and marketing of sugar and ethanol derived from sugarcane, as well as energy derived from the sugar and ethanol production process. The company was founded by Johann Peter Gottlieb Bunge in 1818 and is headquartered in St. Louis, MO. | Agricultural Commodities/Milling | Director of Finance/CFO Comptroller/Controller/Auditor | |
| CENTREXION THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Founder Director/Board Member | |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
Real Chemistry, Inc.
 Real Chemistry, Inc. Data Processing ServicesTechnology Services Real Chemistry, Inc. is an end-to-end healthcare experience group that leverages advanced AI-powered insights, diverse expertise, and customer-centric ideas to transform the healthcare industry. Real Chemistry is based in New York, NY and has subsidiaries in Canada, United Kingdom, and United States. The company helps healthcare professionals better understand, reach, and engage patients, while creating healthcare experiences that span diagnosis to adherence. The company was founded in 2001 by Jim Weiss. Shankar Narayanan has been the CEO of the company since 2022. | Data Processing Services | Corporate Officer/Principal Director/Board Member | |
ORBIS International, Inc.
 ORBIS International, Inc. Hospital/Nursing ManagementHealth Services ORBIS International, Inc. prevents and treats blindness by providing eye care to transform lives. It offers tools, training and technology necessary for local partners to develop eye care services. The company was founded in 1982 by David Paton and is headquartered in New York, NY. | Hospital/Nursing Management | Director/Board Member Director/Board Member | |
| University of Wisconsin | College/University | Masters Business Admin Doctorate Degree | |
The National Organization for Rare Disorders, Inc.
 The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services The National Organization for Rare Disorders, Inc. operates as a non-profit federation of voluntary health organizations to help individuals with diseases and disorders. Its services are focused on the identification, treatment, and cure of disorders through programs of education, advocacy, research, and service. The company was founded in 1983 and is headquartered in Danbury, CT. | Services to the Health Industry | Corporate Officer/Principal Director/Board Member | |
| American Society for Blood & Marrow Transplantation | Corporate Officer/Principal Director/Board Member | ||
| Harvard Business School | College/University | Masters Business Admin Graduate Degree | |
| The University of Texas Southwestern Medical Center | College/University | Doctorate Degree Doctorate Degree | |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | Corporate Officer/Principal General Counsel | |
IconOVir Bio, Inc.
 IconOVir Bio, Inc. BiotechnologyHealth Technology IconOVir Bio, Inc. is an American biotechnology company that operates in the field of life sciences. The company was founded in 2018 by Arie S. Belldegrun, Ben Stone. The CEO is Mark A. McCamish. | Biotechnology | Founder Founder | |
| STRYKER CORPORATION | Medical Specialties | Corporate Officer/Principal Sales & Marketing | |
Kirax Corp.
 Kirax Corp. Pharmaceuticals: MajorHealth Technology Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL. | Pharmaceuticals: Major | Founder Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 47 |
| Verenigd Koninkrijk | 3 |
| Zwitserland | 2 |
| Israël | 2 |
Sectoraal
| Health Technology | 28 |
| Consumer Services | 12 |
| Finance | 3 |
| Health Services | 3 |
| Commercial Services | 2 |
Operationeel
| Director/Board Member | 660 |
| Corporate Officer/Principal | 242 |
| Independent Dir/Board Member | 210 |
| Chairman | 182 |
| Chief Executive Officer | 89 |
Sterkste connecties
| Insiders | |
|---|---|
| David Bonderman | 89 |
| Ernest Mario | 44 |
| Joshua Kazam | 43 |
| Arie Belldegrun | 42 |
| Perry Karsen | 38 |
| Ran Nussbaum | 38 |
| Ian Clark | 35 |
| Thomas Daniel | 35 |
| Robin Washington | 34 |
| Rodman L. Drake | 33 |
| Michael Bonney | 32 |
| Sol Barer | 32 |
| Michael Friedman | 30 |
| Michael Perry | 28 |
| Richard W. Barker | 26 |
- Beurs
- Insiders
- Michele Korfin
- Bedrijfsconnecties
